159 related articles for article (PubMed ID: 29516367)
1. Coronary microvascular dysfunction in hypertrophic cardiomyopathy detected by Rubidium-82 positron emission tomography and cardiac magnetic resonance imaging.
Moody WE; Schmitt M; Arumugam P
J Nucl Cardiol; 2019 Apr; 26(2):666-670. PubMed ID: 29516367
[No Abstract] [Full Text] [Related]
2. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?
Bravo PE
J Nucl Cardiol; 2019 Aug; 26(4):1125-1134. PubMed ID: 29761309
[TBL] [Abstract][Full Text] [Related]
4. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact.
Aguiar Rosa S; Rocha Lopes L; Fiarresga A; Ferreira RC; Mota Carmo M
Microcirculation; 2021 Jan; 28(1):e12656. PubMed ID: 32896949
[TBL] [Abstract][Full Text] [Related]
5. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
[TBL] [Abstract][Full Text] [Related]
6. Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy.
Sotgia B; Sciagrà R; Olivotto I; Casolo G; Rega L; Betti I; Pupi A; Camici PG; Cecchi F
J Nucl Med; 2008 Jul; 49(7):1090-6. PubMed ID: 18552138
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
[TBL] [Abstract][Full Text] [Related]
8. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
Timmer SA; Knaapen P; Germans T; Dijkmans PA; Lubberink M; Ten Berg JM; Ten Cate FJ; Rüssel IK; Götte MJ; Lammertsma AA; van Rossum AC
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H129-37. PubMed ID: 21490327
[TBL] [Abstract][Full Text] [Related]
9. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy mimicking STEMI: The role of cardiac magnetic resonance imaging in the detection of microvascular coronary dysfunction.
Raissuni Z; Doghmi N; Mousseaux E; Cherti M; Redheuil A
Diagn Interv Imaging; 2014 Nov; 95(11):1111-2. PubMed ID: 24560523
[No Abstract] [Full Text] [Related]
11. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.
Camici P; Chiriatti G; Lorenzoni R; Bellina RC; Gistri R; Italiani G; Parodi O; Salvadori PA; Nista N; Papi L
J Am Coll Cardiol; 1991 Mar; 17(4):879-86. PubMed ID: 1999624
[TBL] [Abstract][Full Text] [Related]
12. Positrons, protons, and pulse waves: Multimodality characterization of newly diagnosed hypertrophic cardiomyopathy.
Al-Sabeq B; Soliman A; Chamsi-Pasha M; Shah DJ; Al-Mallah M
J Nucl Cardiol; 2020 Dec; 27(6):2412-2416. PubMed ID: 31898000
[No Abstract] [Full Text] [Related]
13. Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging.
Feher A; Sinusas AJ
Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794138
[TBL] [Abstract][Full Text] [Related]
14. Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy.
Sciagrà R
Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):354-61. PubMed ID: 27611709
[TBL] [Abstract][Full Text] [Related]
15. [Changes in the cardiac vascular bed in dilated and hypertrophic cardiomyopathy].
Rozenberg VD
Kardiologiia; 1989 Nov; 29(11):116-20. PubMed ID: 2615172
[TBL] [Abstract][Full Text] [Related]
16. Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: the index of microvascular resistance.
Gutiérrez-Barrios A; Camacho-Jurado F; Díaz-Retamino E; Gamaza-Chulián S; Agarrado-Luna A; Oneto-Otero J; Del Rio-Lechuga A; Benezet-Mazuecos J
Cardiovasc Revasc Med; 2015; 16(7):426-8. PubMed ID: 26235975
[TBL] [Abstract][Full Text] [Related]
17. Assessment of left ventricular function at rest using rubidium-82 myocardial perfusion PET: comparison of four software algorithms with simultaneous 64-slice coronary CT angiography.
Menezes LJ; Groves AM; Prvulovich E; Dickson JC; Endozo R; Shastry MH; Kayani IA; Papathanasiou ND; Bomanji JB; Ell PJ
Nucl Med Commun; 2009 Dec; 30(12):918-25. PubMed ID: 19884868
[TBL] [Abstract][Full Text] [Related]
18. Myocardial bridges at multiple sites over the left coronary artery in a patient with hypertrophic cardiomyopathy.
Voelker W; Schick KD; Karsch KR
Int J Cardiol; 1989 May; 23(2):258-60. PubMed ID: 2722293
[TBL] [Abstract][Full Text] [Related]
19. Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus.
Potier L; Chequer R; Roussel R; Mohammedi K; Sismail S; Hartemann A; Amouyal C; Marre M; Le Guludec D; Hyafil F
Cardiovasc Diabetol; 2018 Jan; 17(1):11. PubMed ID: 29325551
[TBL] [Abstract][Full Text] [Related]
20. Microvascular dysfunction in infiltrative cardiomyopathies.
Rimoldi O; Maranta F
J Nucl Cardiol; 2019 Feb; 26(1):200-207. PubMed ID: 28699071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
